EFFECTS OF RENIN IN RATS TREATED WITH METHYLANDROSTENEDIOL
- 1 May 1955
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 56 (5) , 541-546
- https://doi.org/10.1210/endo-56-5-541
Abstract
Methylandrostenediol is shown to elicit hypertension and hypertensive vascular lesions in uninephrectomized, salt-fed rats. This hypertensive state resembles the type of hypertension produced by injections of anterior pituitary extracts; both are associated with degenerative changes in the adrenals. The droplets which form in the adrenal cortex react histochemically as muco- or glyco-proteins. Unlike desoxycorticosterone or the adrenal steroids, cortisone and hydrocortisone, MAD does not sensitize to the acute vasculotoxic effects of subcutaneously injected renin. The mechanism of MAD hypertension is distinct from that of DCA hypertension. It may represent an indirect response, possibly mediated by renin, to the stimulus of excessive renal growth.Keywords
This publication has 4 references indexed in Scilit:
- Renin Inhibition of Compensatory Renal Hypertrophy.Experimental Biology and Medicine, 1954
- THE PRODUCTION OF HYPERTENSION, NEPHROSCLEROSIS AND CARDIAC LESIONS BY METHYLANDROSTENEDIOL TREATMENT IN THE RAT1Endocrinology, 1953
- EFFECTS OF RENIN IN RATS PRETREATED WITH HYDROCORTISONE AND SOMATOTROPHINThe Lancet Healthy Longevity, 1953
- EXPERIMENTAL VASCULAR DISEASES DUE TO DESOXYCORTICOSTERONE ACETATE AND ANTERIOR PITUITARY EXTRACT1949